Sinovac PCV13

BIOLOGICAL2 trials

Sponsors

Sinovac Research and Development Co., Ltd., Sinovac Life Sciences Co., Ltd.

Conditions

Pneumococcal Infectious Disease

Phase 1

A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

CompletedNCT06183216

Sinovac Research and Development Co., Ltd.Pneumococcal Infectious Disease

Start: 2024-01-04End: 2025-03-26Updated: 2026-01-28

Phase 3

Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine

RecruitingNCT06617715

Sinovac Life Sciences Co., Ltd.Pneumococcal Infectious Disease

Start: 2024-10-23End: 2026-07-30Target: 3080Updated: 2026-01-28